UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ser38‐His93‐Asn91 triad confers resistance of JFH1 HCV NS5A‐Y93H variant to NS5A inhibitors

The FEBS journal, 2024-03, Vol.291 (6), p.1264-1274

2024

Volltextzugriff (PDF)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma

Cancers, 2020-01, Vol.12 (1), p.182

2020

Volltextzugriff (PDF)

Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma

Journal for immunotherapy of cancer, 2020-08, Vol.8 (2), p.e001072

2020

Volltextzugriff (PDF)

Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle

PLoS pathogens, 2014-05, Vol.10 (5), p.e1004163-e1004163

2014

Volltextzugriff (PDF)

Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol

Scientific reports, 2022-06, Vol.12 (1), p.9942-9942, Article 9942

2022

Volltextzugriff (PDF)

Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11335

2022

Volltextzugriff (PDF)

Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg‐positive cancer patients undergoing chemotherapy

Journal of viral hepatitis, 2018-12, Vol.25 (12), p.1599-1607

2018

Volltextzugriff (PDF)

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Journal of microbiology, immunology and infection, 2021-06, Vol.54 (3), p.385-395

2021

Volltextzugriff (PDF)

Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up

PloS one, 2013-08, Vol.8 (8), p.e72049-e72049

2013

Volltextzugriff (PDF)

Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis

BMC infectious diseases, 2021-09, Vol.21 (1), p.1-12, Article 984

2021

Volltextzugriff (PDF)

Multiple effects of honokiol on the life cycle of hepatitis C virus

Liver international, 2012-07, Vol.32 (6), p.989-997

2012

Volltextzugriff (PDF)

Novel Cell-Based Hepatitis C Virus Infection Assay for Quantitative High-Throughput Screening of Anti-Hepatitis C Virus Compounds

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.995-1004

2014

Volltextzugriff (PDF)

Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B

Journal of the Formosan Medical Association, 2021-09, Vol.120 (9), p.1676-1685

2021

Volltextzugriff (PDF)

Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus

The American journal of Chinese medicine (1979), 2018, Vol.46 (4), p.835-852

2018

Volltextzugriff (PDF)

Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells

Oncotarget, 2017-12, Vol.8 (69), p.113460-113471

2017

Volltextzugriff (PDF)

Helicobacter pylori-induced chronic inflammation causes telomere shortening of gastric mucosa by promoting PARP-1-mediated non-homologous end joining of DNA

Archives of biochemistry and biophysics, 2016-09, Vol.606, p.90-98

2016

Volltextzugriff (PDF)

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221099401

2022

Volltextzugriff (PDF)

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

Oncogene, 2002-07, Vol.21 (31), p.4801-4811

2002

Volltextzugriff (PDF)

Phosphorylation accelerates geldanamycin-induced Akt degradation

Archives of biochemistry and biophysics, 2013-08, Vol.536 (1), p.6-11

2013

Volltextzugriff (PDF)

The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population

Clinical cancer research, 2005-09, Vol.11 (18), p.6431-6441

2005

Volltextzugriff (PDF)

Tpl2 Inhibitors Thwart Endothelial Cell Function in Angiogenesis and Peritoneal Dissemination

Neoplasia (New York, N.Y.), 2013-09, Vol.15 (9), p.1036-IN4

2013

Volltextzugriff (PDF)

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer

Hepatology (Baltimore, Md.), 2000-08, Vol.32 (2), p.405-412

2000

Volltextzugriff (PDF)

Akt1 is involved in HCV release by promoting endoplasmic reticulum-to-endosome transition of infectious virions

Life sciences (1973), 2024-02, Vol.338, p.122412-122412, Article 122412

2024

Volltextzugriff (PDF)

Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance

Life sciences (1973), 2024-01, Vol.337, p.122338-122338, Article 122338

2024

Volltextzugriff (PDF)

Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt

Archives of biochemistry and biophysics, 2012-12, Vol.528 (2), p.156-162

2012

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ser38‐His93‐Asn91 triad confers resistance of JFH1 HCV NS5A‐Y93H variant to NS5A inhibitors

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma

Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma

Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle

Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol

Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg‐positive cancer patients undergoing chemotherapy

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up

Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis

Multiple effects of honokiol on the life cycle of hepatitis C virus

Novel Cell-Based Hepatitis C Virus Infection Assay for Quantitative High-Throughput Screening of Anti-Hepatitis C Virus Compounds

Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B

Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus

Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells

Helicobacter pylori-induced chronic inflammation causes telomere shortening of gastric mucosa by promoting PARP-1-mediated non-homologous end joining of DNA

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

Phosphorylation accelerates geldanamycin-induced Akt degradation

The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population

Tpl2 Inhibitors Thwart Endothelial Cell Function in Angiogenesis and Peritoneal Dissemination

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer

Akt1 is involved in HCV release by promoting endoplasmic reticulum-to-endosome transition of infectious virions

Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance

Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt

Suchergebnisse filtern